GMP in Emerging Markets (GCC, Latin America, Africa)

How to Implement CAPA for GMP Compliance in Emerging Markets A Step-by-Step Guide to Implementing CAPA for GMP Compliance in Emerging Markets Introduction to CAPA and GMP Compliance Corrective and Preventive Action (CAPA) is an essential component of Good Manufacturing Practices (GMP) in pharmaceutical manufacturing. CAPA ensures that non-conformities are addressed effectively, and measures are…

Read More “How to Implement CAPA for GMP Compliance in Emerging Markets” »

Best Practices for GMP Compliance in High-Risk Drug Manufacturing in Emerging Markets GMP Compliance Strategies for High-Risk Drug Manufacturing in Emerging Markets Introduction to High-Risk Drug Manufacturing and GMP Compliance Manufacturing high-risk drugs, such as sterile injectables, biologics, and controlled substances, requires strict adherence to Good Manufacturing Practices (GMP). These products are more susceptible to…

Read More “Best Practices for GMP Compliance in High-Risk Drug Manufacturing in Emerging Markets” »